EOLS
Evolus Inc
NASDAQ: EOLS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$5.18
-1.71% today
Updated 2026-04-29
Market cap
$344.82M
P/E ratio
—
P/S ratio
1.16x
EPS (TTM)
$-0.80
Dividend yield
—
52W range
$4 – $12
Volume
1.1M
Evolus Inc (EOLS) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-36.38M | $-13.27M | $-13.04M | $-25.67M | $-93.38M | $-57.87M | $-33.39M | $-84.91M | $-34.01M | $-18.00M | $-42.27M |
| Capital expenditures | $9000.00 | $9000.00 | $9000.00 | $9000.00 | $4.57M | $3.14M | $970000.00 | $2.94M | $1.63M | $1.47M | $3.44M |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $1.51M | $957000.00 | $586000.00 | $6.97M | $9.52M | $10.58M | $9.58M | $10.83M | $16.46M | $22.25M | $20.70M |
| Free cash flow | $-36.39M | $-13.28M | $-13.04M | $-25.68M | $-97.95M | $-61.01M | $-34.36M | $-87.85M | $-35.63M | $-19.47M | $-45.71M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | $93.16M | $16.73M | $-7.33M | $43.69M | $-92.00M | — | — | — |